GIC-Backed WCG Clinical Plans $100M NASDAQ Debut
WCG Clinical Inc (NASDAQ: WCGC), a clinical trial solutions company backed by Singapore's sovereign wealth fund GIC, filed for an initial public offering in the U.S. on Thursday to trade on NASDAQ under the "WCGC" symbol.